
News|Articles|October 1, 2006
Infliximab
TNF inhibitor approved for inhibiting joint damage, improving physical function in psoriatic arthritis
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























